Clinical Validation of PBRM1 Alterations as a Marker of Immune Checkpoint Inhibitor Response in Renal Cell Carcinoma

被引：181
|
作者：
Braun, David A. [1 ]
Ishii, Yuko [2 ]
Walsh, Alice M. [2 ]
Van Allen, Eliezer M. [1 ]
Wu, Catherine J. [1 ]
Shukla, Sachet A. [1 ]
Choueiri, Toni K. [1 ]
机构：
[1] Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA
[2] Bristol Myers Squibb, Lawrenceville, NJ USA
来源：
JAMA ONCOLOGY | 2019年 / 5卷 / 11期
关键词：
D O I：
10.1001/jamaoncol.2019.3158
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1631 / 1633
页数：3
相关论文
共 50 条
  • [31] Paradoxical Effect of Myosteatosis on the Immune Checkpoint Inhibitor Response in Metastatic Renal Cell Carcinoma
    Yu, Jiwoong
    Ahn, Hyeonju
    Han, Kyung Yeon
    Song, Wan
    Sung, Hyun Hwan
    Jeon, Hwang Gyun
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Park, Se Hoon
    Park, Woong-Yang
    Lee, Ji Hyun
    Kang, Minyong
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2025, 16 (02)
  • [32] PBRM1 presents a potential prognostic marker and therapeutic target in duodenal papillary carcinoma
    He, Xujun
    Xu, Ji
    Niu, Nan
    Xu, Guoxi
    Zhu, Honglin
    Liu, Zhengchuang
    Mou, Yiping
    Qian, Zhengyuan
    Wang, Huiju
    Hu, Junfeng
    Ma, Tonghui
    Ma, Jie
    Tao, Houquan
    CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 12 (10):
  • [33] The Suggested Importance of PBRM1 Mutation in Predicting Postoperative Recurrence of Localized Clear Cell Renal Cell Carcinoma
    Goldberg, Hanan
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (04) : 1889 - 1891
  • [34] PBRM1 genomic alterations as a predictive biomarker to immune checkpoint inhibitors (ICI) and/or anti-angiogenic therapies (anti-VEGF) in metastatic renal cell carcinoma (mRCC): A systematic review and meta-analysis.
    Ghiglione, Lucio
    Fernandez-Manas, Laia
    Ferrer-Mileo, Laura
    Aversa, Caterina
    Garcia de Herreros, Marta
    Carlos Laguna, Juan
    Gorria, Teresa
    Marin, Mercedes
    Jimenez, Natalia
    Prat, Aleix
    Maurel, Joan
    Mellado, Begona
    Reig, Oscar
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16515 - E16515
  • [35] Inactivation of the PBRM1 tumor suppressor gene amplifies the HIF-response in VHL-/- clear cell renal carcinoma
    Gao, Wenhua
    Li, Wei
    Xiao, Tengfei
    Liu, Xiaole Shirley
    Kaelin, William G., Jr.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (05) : 1027 - 1032
  • [36] The Suggested Importance of PBRM1 Mutation in Predicting Postoperative Recurrence of Localized Clear Cell Renal Cell Carcinoma
    Hanan Goldberg
    Annals of Surgical Oncology, 2021, 28 : 1889 - 1891
  • [37] PBRM1 alteration in clear cell renal cell carcinoma increases tumorigenicity through ALDH1A1 upregulation
    Schoenfeld, David
    Su, William
    Zairis, Sakellarios
    Mathur, Deepti
    Rabadan, Raul
    Parsons, Ramon
    CANCER RESEARCH, 2016, 76
  • [38] PBRM1 loss defines distinct tumor phenotype associated with immunotherapy resistance in renal cell carcinoma
    Liu, Xiande
    Kong, Wen
    Peterson, Christine
    McGrail, Daniel
    Anh Hoang
    Zhang, Xuesong
    Truong Lam
    Pilie, Patrick
    Zhu, Haifeng
    Beckermann, Kathryn
    Haake, Scott
    Isgandrova, Sevinj
    Martinez-Moczygemba, Margarita
    Sahni, Nidhi
    Rathmell, W. Kimryn
    Jonasch, Eric
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [39] Inactivation of PBRM1, a gene frequently mutated in clear cell renal carcinoma, suppresses tumor growth
    Huang Dachuan
    Kiat, Ong Choon
    Bin Tean, Teh
    Huimin, Bernice Wong
    Chan-on, Waraporn
    Subimerb, Chutima
    Furge, Kyle
    Futreal, Andrew
    CANCER RESEARCH, 2011, 71
  • [40] Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation
    Kapur, Payal
    Pena-Llopis, Samuel
    Christie, Alana
    Zhrebker, Leah
    Pavia-Jimenez, Andrea
    Rathmell, W. Kimryn
    Xie, Xian-Jin
    Brugarolas, James
    LANCET ONCOLOGY, 2013, 14 (02): : 159 - 167
12345